Annual report [Section 13 and 15(d), not S-K Item 405]

Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.25.2
Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Earnings Per Share      
Net earnings, including noncontrolling interest $ 73,400 $ 168,105 $ 285,442
Less net earnings attributable to noncontrolling interest     179
Net earnings attributable to Bio-Techne 73,400 168,105 285,263
Income allocated to participating securities (37) (33) (70)
Income available to common shareholders $ 73,363 $ 168,072 $ 285,193
Weighted-average shares outstanding - basic (in shares) 157,521 157,708 157,179
Earnings per share - basic $ 0.47 $ 1.07 $ 1.81
Income available to common shareholders $ 73,363 $ 168,072 $ 285,193
Dilutive effect of stock options and restricted stock units (in shares) 2,196 3,066 4,676
Weighted-average common shares outstanding - diluted (in shares) 159,717 160,774 161,855
Earnings per share - diluted $ 0.46 $ 1.05 $ 1.76